搜索临床试验以:OX40 ligand (OX40)
总计594个结果
-
Merck Sharp & Dohme LLC终止
-
Wenbin QianZhejiang Provincial Tongde Hospital未知
-
Janssen Research & Development, LLC完全的
-
Merck Sharp & Dohme LLC撤销多发性骨髓瘤美国, 加拿大, 法国, 以色列, 西班牙, 瑞典
-
Dartmouth-Hitchcock Medical CenterBristol-Myers Squibb; Ligand Pharmaceuticals终止
-
Nantes University HospitalCentre de Recherche en cancérologie Nantes-Angers - CRCNA完全的
-
Fondazione Ricerca Traslazionale未知定义一个简单可行的组合,可以常规应用于选择患者进行免疫治疗,避免更复杂和昂贵的方法
-
Dartmouth-Hitchcock Medical CenterGenentech, Inc.; Ligand Pharmaceuticals完全的
-
Genentech, Inc.完全的
-
Genentech, Inc.完全的血液系统恶性肿瘤 | 肿瘤西班牙, 法国, 美国, 英国
-
Janssen Research & Development, LLC完全的
-
University Hospital, LilleInstitut National de la Santé Et de la Recherche Médicale, France; French National Society of...完全的
-
Centre Hospitalier Universitaire, Amiens完全的
-
Celyad Oncology SANational Heart, Lung, and Blood Institute (NHLBI); Dana-Farber Cancer Institute完全的
-
National Institute of Diabetes and Digestive and...完全的
-
Stanford UniversityNational Cancer Institute (NCI)完全的
-
Lundbeck LLCQuintiles, Inc.; ICON Clinical Research; Ligand Pharmaceuticals完全的
-
University of ZurichUniversity Hospital Inselspital, Berne; Swiss Paraplegic Centre Nottwil; Cantonal Hospital of...完全的
-
University Hospital, BordeauxMinistry for Health and Solidarity, France完全的
-
National Institute of Allergy and Infectious Diseases...终止
-
Indonesia UniversityNetherlands: Ministry of Health, Welfare and Sports完全的
-
Luis Fernando SimonetiFundação de Amparo à Pesquisa do Estado de São Paulo完全的